EUVIMEDEUVIMED entdecken
Crossref

YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis

Da Gu, Yulin Sun, Jinpeng Sun, Weiting Kang iD, Huanmin Lou, Xiaojing Li

Medical Oncology · 2026

DOI: 10.1007/s12032-026-03427-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Da Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. Hauptthemen laut MEDLINE: Ferroptosis, RNA-Binding Proteins, Melanoma, Skin Neoplasms. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Jinan Central Hospital High-level Research Cultivation Program, Shandong Provincial Natural Science Foundation, Shandong First Medical University (Shandong Academy of Medical Sciences) Youth Science Foundation Incubation Grant Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) modification plays a critical role in eukaryotic mRNA and is significantly associated with cutaneous melanoma. This study investigated the role of the m6A-binding protein YTHDF2 in the pathogenesis of cutaneous melanoma and its potential therapeutic applications. Analyses of public databases indicated that YTHDF2 exhibited elevated expression in various cancers, including cutaneous melanoma, where its levels positively correlated with PD-L1 and negatively correlated with immune and stromal scores. Functionally, the downregulation of YTHDF2 in melanoma cells suppressed proliferation and increased the population of Annexin V/PI--positive cells, an effect that was rescued by the ferroptosis inhibitor, highlighting YTHDF2’s involvement in ferroptosis regulation. YTHDF2 knockdown resulted in increased intracellular Fe^2+ levels, malondialdehyde, reactive oxygen species, and lipid peroxidation, alongside a reduction in glutathione—effects that were reversed upon ferroptosis inhibition. In vivo studies corroborated the regulatory role of YTHDF2 in ferroptosis. Mechanistically, integrated RNA-seq and RIP-seq analyses demonstrated that YTHDF2 could bind to m6A on HMOX1 transcripts, destabilizing its mRNA and thus regulating HMOX1 expression. Moreover, metformin was shown to inhibit YTHDF2 expression, promoting ferroptosis in melanoma cells. In summary, YTHDF2 modulates ferroptosis in melanoma through the regulation of m6A-dependent HMOX1 mRNA stability, suggesting it as a promising therapeutic target. The capacity of metformin to suppress YTHDF2 indicates its potential utility in hindering melanoma progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisRNA-Binding ProteinsMelanomaSkin NeoplasmsAdenosineHeme Oxygenase-1HumansAnimalsMiceDisease ProgressionCutaneous Malignant MelanomaCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticRNA Methylation

Stichwörter der Autor:innen

Cutaneous MelanomaFerroptosisHMOX1M6AYTHDF2

Substanzen

RNA-Binding ProteinsYTHDF2 protein, humanAdenosineHeme Oxygenase-1N-methyladenosineHMOX1 protein, human

Autor:innen und Institutionen

  • Department of Plastic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China.
  • Department of Plastic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China.
  • Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
  • Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. kangweiting@sdfmu.edu.cn.
  • Department of Plastic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China. 13370582901@189.cn.
  • Department of Plastic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. yfy130377@fy.ahmu.edu.cn.

ORCID-Profile: Weiting Kang

Förderung

  • Jinan Central Hospital High-level Research Cultivation Program
  • Shandong Provincial Natural Science Foundation
  • Shandong First Medical University (Shandong Academy of Medical Sciences) Youth Science Foundation Incubation Grant Program
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Gu, D., Sun, Y., Sun, J., Kang, W., Lou, H., & Li, X. (2026). YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis. Medical Oncology. https://doi.org/10.1007/s12032-026-03427-y

Vancouver

Gu D, Sun Y, Sun J, Kang W, Lou H, Li X. YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis. Medical Oncology. 2026. doi:10.1007/s12032-026-03427-y

BibTeX
@article{Gu2026,
  author = {Gu, Da and Sun, Yulin and Sun, Jinpeng and Kang, Weiting and Lou, Huanmin and Li, Xiaojing},
  title = {YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis},
  journal = {Medical Oncology},
  year = {2026},
  doi = {10.1007/s12032-026-03427-y}
}
Kostenlos starten →